Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Handling Stress and Sample Storage Are Associated with Weaker Complement-Mediated Bactericidal Ability in Birds but Not Bats.

Becker DJ, Czirják GÁ, Rynda-Apple A, Plowright RK.

Physiol Biochem Zool. 2019 Jan/Feb;92(1):37-48. doi: 10.1086/701069.

PMID:
30481115
2.

IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.

Shepardson KM, Larson K, Johns LL, Stanek K, Cho H, Wellham J, Henderson H, Rynda-Apple A.

Front Immunol. 2018 Nov 9;9:2589. doi: 10.3389/fimmu.2018.02589. eCollection 2018.

3.

Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.

Klonoski JM, Watson T, Bickett TE, Svendsen JM, Gau TJ, Britt A, Nelson JT, Schlenker EH, Chaussee MS, Rynda-Apple A, Huber VC.

Viral Immunol. 2018 Jul/Aug;31(6):457-469. doi: 10.1089/vim.2017.0193. Epub 2018 Jun 5.

PMID:
29870311
4.

Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.

Shepardson KM, Schwarz B, Larson K, Morton RV, Avera J, McCoy K, Caffrey A, Harmsen A, Douglas T, Rynda-Apple A.

MBio. 2017 Nov 14;8(6). pii: e01356-17. doi: 10.1128/mBio.01356-17.

5.

Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.

Huarte E, Jun S, Rynda-Apple A, Golden S, Jackiw L, Hoffman C, Maddaloni M, Pascual DW.

J Immunol. 2016 Jun 15;196(12):5036-46. doi: 10.4049/jimmunol.1501973. Epub 2016 May 18.

6.

Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.

Shepardson KM, Larson K, Morton RV, Prigge JR, Schmidt EE, Huber VC, Rynda-Apple A.

MBio. 2016 May 3;7(3). pii: e00506-16. doi: 10.1128/mBio.00506-16.

7.

Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein.

Schwarz B, Madden P, Avera J, Gordon B, Larson K, Miettinen HM, Uchida M, LaFrance B, Basu G, Rynda-Apple A, Douglas T.

ACS Nano. 2015 Sep 22;9(9):9134-47. doi: 10.1021/acsnano.5b03360. Epub 2015 Aug 18.

8.

Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease.

Rynda-Apple A, Robinson KM, Alcorn JF.

Infect Immun. 2015 Oct;83(10):3764-70. doi: 10.1128/IAI.00298-15. Epub 2015 Jul 27. Review.

9.

Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung.

Rynda-Apple A, Patterson DP, Douglas T.

Nanomedicine (Lond). 2014;9(12):1857-68. doi: 10.2217/nnm.14.107. Review.

10.

Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia.

Rynda-Apple A, Harmsen A, Erickson AS, Larson K, Morton RV, Richert LE, Harmsen AG.

Eur J Immunol. 2014 Nov;44(11):3263-72. doi: 10.1002/eji.201444582. Epub 2014 Sep 1.

11.

Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses.

Richert LE, Harmsen AL, Rynda-Apple A, Wiley JA, Servid AE, Douglas T, Harmsen AG.

Lymphat Res Biol. 2013 Dec;11(4):196-202. doi: 10.1089/lrb.2013.0015.

12.

CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.

Richert LE, Rynda-Apple A, Harmsen AL, Han S, Wiley JA, Douglas T, Larson K, Morton RV, Harmsen AG.

Eur J Immunol. 2014 Feb;44(2):397-408. doi: 10.1002/eji.201343587. Epub 2014 Jan 13.

13.

NKG2D CAR T-cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors.

Spear P, Barber A, Rynda-Apple A, Sentman CL.

Immunol Cell Biol. 2013 Jul;91(6):435-40. doi: 10.1038/icb.2013.17. Epub 2013 Apr 30.

14.

Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.

Patterson DP, Rynda-Apple A, Harmsen AL, Harmsen AG, Douglas T.

ACS Nano. 2013 Apr 23;7(4):3036-44. doi: 10.1021/nn4006544. Epub 2013 Apr 10.

15.

Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.

Rynda-Apple A, Dobrinen E, McAlpine M, Read A, Harmsen A, Richert LE, Calverley M, Pallister K, Voyich J, Wiley JA, Johnson B, Young M, Douglas T, Harmsen AG.

Am J Pathol. 2012 Jul;181(1):196-210. doi: 10.1016/j.ajpath.2012.03.018. Epub 2012 May 26.

16.

Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF.

Spear P, Barber A, Rynda-Apple A, Sentman CL.

J Immunol. 2012 Jun 15;188(12):6389-98. doi: 10.4049/jimmunol.1103019. Epub 2012 May 14. Erratum in: J Immunol. 2014 Aug 1;193(3):1513.

17.

Loss of sialic acid binding domain redirects protein σ1 to enhance M cell-directed vaccination.

Zlotkowska D, Maddaloni M, Riccardi C, Walters N, Holderness K, Callis G, Rynda-Apple A, Pascual DW.

PLoS One. 2012;7(4):e36182. doi: 10.1371/journal.pone.0036182. Epub 2012 Apr 30.

18.

A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.

Richert LE, Servid AE, Harmsen AL, Rynda-Apple A, Han S, Wiley JA, Douglas T, Harmsen AG.

Vaccine. 2012 May 21;30(24):3653-65. doi: 10.1016/j.vaccine.2012.03.035. Epub 2012 Mar 28.

19.

Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.

Huarte E, Rynda-Apple A, Riccardi C, Skyberg JA, Golden S, Rollins MF, Ramstead AG, Jackiw LO, Maddaloni M, Pascual DW.

J Autoimmun. 2011 Dec;37(4):328-41. doi: 10.1016/j.jaut.2011.09.005. Epub 2011 Oct 22.

20.

Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.

Rynda-Apple A, Huarte E, Maddaloni M, Callis G, Skyberg JA, Pascual DW.

Eur J Immunol. 2011 Feb;41(2):313-23. doi: 10.1002/eji.201041104. Epub 2010 Dec 29.

Supplemental Content

Loading ...
Support Center